What is Diabetes Type 2?

Diabetes type 2 is a condition in which the body is resistant to insulin resulting in high blood sugar levels. Symptoms include fatigue, hunger, thirst, increased urination, and tingling in feet and hands.

Treatment for diabetes type 2 includes medication, diet, and exercise. Common drug classes used to treat diabetes type 2 are biguanides, insulins, sulfonylureas, gliptins, glitazones, sulfonylurea / biguanide combinations, gliptin / biguanide combinations, GLP-1 agonists, ergot derivatives, glinides, glitazone / biguanide combinations, alpha glucosidase inhibitors, amlyn analogues, glitazone / sulfonylurea combinations, gliptin / statin combinations, gliptin / glitazone combinations, SGLT2 inhibitors, and glinide / biguanide combinations.

Savings Tips for Diabetes Type 2

  • FDA Approves Soliqua for Type 2 Diabetes

    December 13, 2016

    As 2016 comes to a close, we have some news in the world of diabetes medications! The FDA has recently released Soliqua 100/33, a combination medication for the treatment of type 2 diabetes.

    Type 2 diabetes can be very tricky and hard to control. Therefore, the discovery and approval of these new oral and injectable medications are important for healthcare providers and their patients.

    What is Soliqua 100/33 indicated for?

    Soliqua 100/33 is prescribed to improve glycemic control in adults with type 2 diabetes, in conjunction with diet and exercise. See More

  • New FDA Safety Alert: Invokana and Farxiga for Diabetes

    July 06, 2016

    In June 2016, the FDA issued a safety alert for canagliflozin (Invokana, Invokamet), used to treat type 2 diabetes.

    Now, another warning has been issued, for Invokana and Invokamet along with another similar diabetes medication, dapagliflozin (Farxiga and Xigduo XR).

    According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More

  • New Combo Drug Jentadueto XR Approved for Diabetes

    June 23, 2016

    Jentadueto XR (metformin/linagliptin) is the newest once-daily combination drug approved by the FDA to treat type 2 diabetes.

    Combination drugs can also be a convenient way to join together two drugs that work differently to treat a particular health condition, and extended release versions like Jentadueto XR mean you only need to take your prescription once per day. In addition, many medications are combined because they work better together than either medication alone. See More

see all savings tips

Popular Diabetes Type 2 Drugs

Popularity Drug Name Drug Class Price
Biguanides 6 See Prices
Insulins 385 See Prices
Biguanides 9 See Prices
see all 124 drugs

Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Diabetes Type 2 Drug Classes

Copyright ©2017 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.